Ff. Lin et al., CLONING AND STABLE EXPRESSION OF THE MGLUR1B SUBTYPE OF HUMAN METABOTROPIC RECEPTORS AND PHARMACOLOGICAL COMPARISON WITH THE MGLUR5A SUBTYPE, Neuropharmacology, 36(7), 1997, pp. 917-931
We isolated and characterized a cDNA encoding the human metabotropic g
lutamate receptor subtype 1b (hmGluR1b). In situ hybridization studies
in human brain regions revealed a higher distribution of mGluR1 mRNA
in the dentate gyrus of the hippocampus, the substantia nigra pars com
pacta and the Purkinje cell layer of the cerebellum compared to other
regions studied. We established stable expression of recombinant hmGlu
R1b in L(tk(-)) mouse fibroblast and Chinese hamster ovary (CHO-dhfr(-
)) cells. In both expression systems, agonist activation of hmGluR1b s
timulated inositol phosphate (InsP) formation and elevation of the cyt
osolic free calcium ([Ca2+](i)), and both responses were blocked by (S
)-MCPG. The rank order of potency for agonists was quisqualate > gluta
mate, (IS,3R)-ACPD in both expression systems. Comparison of the agoni
st profiles of hmGluR1b and hmGluR5a, both stably expressed in L(tk(-)
) cells, indicated the same rank order of potency (quisqualate > gluta
mate greater than or equal to (RS)-3,5-DHPG greater than or equal to (
1S,3R)-ACPD), but each of the four agonists were more potent on hmGluR
5a than on hmGluR1b. In antagonist studies, (S)-MCPG inhibited the ago
nist-induced InsP formation and elevation of [Ca2+](i) in both hmGluR1
b- and hmGluR5a-expressing cells. (S)-4CPG and (S)-4C3HPG both inhibit
ed agonist responses only in hmGluR1b-expressing cells. However, in hm
GluR5a-expressing cells the antagonist activity of(S)-4CPG and (S)-4C3
HPG was dependent on the agonist used in the study, since they inhibit
ed responses to glutamate but not to quisqualate. Stable cell lines ex
pressing specific subtypes of human mGluRs represent valuable tools fo
r the study of the mechanism of action of mGluRs at the molecular and
cellular level and as screening targets for identification of subtype-
selective agonists or antagonists. (C) 1997 Elsevier Science Ltd.